| Title |
Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia
|
|---|---|
| Published in |
Current Infectious Disease Reports, February 2013
|
| DOI | 10.1007/s11908-013-0327-3 |
| Pubmed ID | |
| Authors |
Nikole M. Scalera, Thomas M. File |
| Abstract |
Emerging data, including results from two systematic reviews, suggest that with appropriate antimicrobial selection, community-acquired pneumonia (CAP) can be successfully treated in less than 7 days, rather than the 7-14 days frequently utilized. Shorter course therapy has the potential not only to improve efficacy, safety, and compliance, but also to minimize the evolution of resistance. Utilization of procalcitonin as a biomarker in CAP can appropriately influence the duration of therapy without affecting mortality and cure rates. CAP treatment duration can further be reduced successfully into the clinical setting with the assistance of an antibiotic stewardship team. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 2% |
| Unknown | 50 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 14% |
| Student > Master | 7 | 14% |
| Student > Bachelor | 5 | 10% |
| Student > Postgraduate | 4 | 8% |
| Other | 3 | 6% |
| Other | 10 | 20% |
| Unknown | 15 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 53% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
| Veterinary Science and Veterinary Medicine | 1 | 2% |
| Social Sciences | 1 | 2% |
| Biochemistry, Genetics and Molecular Biology | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 17 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 September 2019.
All research outputs
#6,389,271
of 22,701,287 outputs
Outputs from Current Infectious Disease Reports
#141
of 487 outputs
Outputs of similar age
#53,222
of 192,971 outputs
Outputs of similar age from Current Infectious Disease Reports
#3
of 7 outputs
Altmetric has tracked 22,701,287 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 487 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,971 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.